ArticleJACC. Case reports2026
Hereditary Transthyretin Amyloidosis in Brazilian Amazon Caused by a Globally Rare Variant Predominant in Asia.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHereditary transthyretin amyloidosis (ATTRv) exhibits marked phenotypic heterogeneity. The p.Asp58Ala variant is globally rare and has not been reported in major Brazilian epidemiologic studies. CASE SUMMARY: We report 10 patients with ATTRv-p.Asp58Ala, including 6 index cases and 4 identified through family screening. Mean left ventricular ejection fraction was 64.7%, with a mean interventricular wall thickness of 14.1 mm and a mean posterior wall thickness of 12.9 mm. Mixed cardiac and neurologic involvement predominated (60%), followed by asymptomatic (30%) and isolated cardiac (10%) phenotypes. Among 7 patients under follow-up, 2 receive tafamidis and 1 receives inotersen. DISCUSSION: Similar to Korean and other Asian cohorts, mixed phenotypes predominated, although our series showed substantial cardiac involvement and significant mortality. TAKE-HOME MESSAGES: p.Asp58Ala is a rare ATTR variant, previously described mainly in Asian populations. Its identification in the Amazon region suggests a possible previously unreported regional clustering in Brazil.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.